Senior Vice President and Chief Financial Officer
United States of America
Bringing more than 20 years of finance, accounting and tax management experience, Felicia Ladin joined AMRI in 2015. A CPA by training, Ms. Ladin has spent the majority of her career in the pharmaceutical industry, most recently as senior vice president and CFO of global specialty medicines at Teva Pharmaceuticals Industries. Before that, she held positions of increasing responsibility directing Teva’s financial planning and analysis operations, and was tax director for the U.S. prior to that. During her 12-year tenure at Teva, Ms. Ladin developed and implemented financial systems and infrastructure through numerous acquisitions and drove consistency and efficiencies across locations, supporting the specialty medicine division’s growth into an $8 billion global business.
Finance , Accounting , Tax management and Pharmaceutical Science